Dihydromyricetin Exhibits Antitumor Activity in Nasopharyngeal Cancer Cell Through Antagonizing Wnt/β-catenin Signaling

被引:12
作者
Ye, Ling [1 ]
Yin, Gendi [2 ]
Jiang, Miaohua [1 ]
Tu, Bo [1 ]
Li, Zhicheng [2 ]
Wang, Yiming [1 ]
机构
[1] Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China
关键词
dihydromyricetin; Wnt/beta-catenin signaling; nasopharyngeal cancer; cancer stem cell; BETA-CATENIN; WNT CORECEPTOR; BREAST-CANCER; IN-VITRO; ACTIVATION; PHOSPHORYLATION; RESISTANCE; PATHWAY;
D O I
10.1177/1534735421991217
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Cancer stem cells (CSCs) have been demonstrated to play a vital role in a diversity of biological processes in cancers. With the emergence of new evidence, the important function of CSCs in the formation of multidrug resistance of nasopharyngeal cancer has been demonstrated. Dysregulated Wnt/beta-catenin signaling pathway is an important contributor to chemoresistance and maintenance of CSCs-like characteristics. This research aims to investigate comprehensively the function of dihydromyricetin (DMY), a natural flavonoid drug, on the cisplatin (cis) resistance and stem cell properties of nasopharyngeal cancer. Methods: In this study, the functional role of DMY in nasopharyngeal cancer progression was comprehensively investigated in vitro and in vivo, and then its relationship with CSCs-like phenotypes and multiple oncogenes was analyzed. Results: In parallel assays, the growth inhibitory action of cis was enhanced by the addition of DMY in cisresistant nasopharyngeal cancer cell lines (HoneI/cis and CNEI/cis). Functional assays showed that DMY markedly diminished the stem cell properties of nasopharyngeal cells, such as colony and tumor-sphere formation. In vivo data showed that the growth of Hone I CSCs formed tumor xenograft was inhibited significantly by the administration of DMY. Additionally, DMY could impair the Wnt/beta-catenin signaling pathway and regulate the expression of downstream proteins in nasopharyngeal cancer cells. Conclusions: Our study clarified the anti-tumor activity of DMY through blocking the Wnt/beta-catenin signaling pathway in nasopharyngeal cancer. Therefore, DMY could be a novel therapeutic agent for nasopharyngeal cancer treatment.
引用
收藏
页数:13
相关论文
共 50 条
[31]   The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells [J].
Reabroi, Somrudee ;
Saeeng, Rungnapha ;
Boonmuen, Nittaya ;
Kasemsuk, Teerapich ;
Saengsawang, Witchuda ;
Suksen, Kanoknetr ;
Zhu, Weiming ;
Piyachaturawat, Pawinee ;
Chairoungdua, Arthit .
SCIENTIFIC REPORTS, 2018, 8
[32]   CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment [J].
Kim, Ji-Young ;
Lee, Hwa-Yong ;
Park, Kwan-Kyu ;
Choi, Yang-Kyu ;
Nam, Jeong-Seok ;
Hong, In-Sun .
ONCOTARGET, 2016, 7 (15) :20395-20409
[33]   The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway [J].
Li, Hongkun ;
Li, Jiawei ;
Zhang, Yifan ;
Zhao, Chengcheng ;
Ge, Jun ;
Sun, Yujiao ;
Fu, Hui ;
Li, Yingpeng .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[34]   MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling [J].
Guan, Han ;
Liu, Chunhui ;
Fang, Fang ;
Huang, Yeqing ;
Tao, Tao ;
Ling, Zhixin ;
You, Zonghao ;
Han, Xu ;
Chen, Shuqiu ;
Xu, Bin ;
Chen, Ming .
ONCOTARGET, 2017, 8 (09) :14693-14707
[35]   Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer [J].
Qu, Yi ;
Gharbi, Naouel ;
Yuan, Xing ;
Olsen, Jan Roger ;
Blicher, Pernille ;
Dalhus, Bjorn ;
Brokstad, Karl A. ;
Lin, Biaoyang ;
Oyan, Anne Margrete ;
Zhang, Weidong ;
Kalland, Karl-Henning ;
Ke, Xisong .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (33) :9339-9344
[36]   LRP16 prevents hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling [J].
Shao, Lijuan ;
Jing, Wei ;
Wang, Lingxiong ;
Pan, Fei ;
Wu, Liangliang ;
Zhang, Lijun ;
Yang, Pan ;
Hu, Minggen ;
Fan, Kexing .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2018, 96 (06) :547-558
[37]   The Antitumor Activity of Antrodia camphorata in Melanoma Cells: Modulation of Wnt/β-Catenin Signaling Pathways [J].
Hseu, You-Cheng ;
Tsou, Hsiao-Tung ;
Kumar, K. J. Senthil ;
Lin, Kai-Yuan ;
Chang, Hsueh-Wei ;
Yang, Hsin-Ling .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
[38]   TRAF4 participates in Wnt/β-catenin signaling in breast cancer by upregulating β-catenin and mediating its translocation to the nucleus [J].
Wang, Ailian ;
Wang, Jian ;
Ren, Huanyan ;
Yang, Fan ;
Sun, Lili ;
Diao, Kexin ;
Zhao, Zhijuan ;
Song, Min ;
Cui, Zeshi ;
Wang, Enhua ;
Wei, Minjie ;
Mi, Xiaoyi .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 395 (1-2) :211-219
[39]   The Flavonol Quercitrin Hinders GSK3 Activity and Potentiates the Wnt/β-Catenin Signaling Pathway [J].
Predes, Danilo ;
Maia, Lorena A. ;
Matias, Isadora ;
Araujo, Hannah Paola Mota ;
Soares, Carolina ;
Barros-Aragao, Fernanda G. Q. ;
Oliveira, Luiz F. S. ;
Reis, Renata R. ;
Amado, Nathalia G. ;
Simas, Alessandro B. C. ;
Mendes, Fabio A. ;
Gomes, Flavia C. A. ;
Figueiredo, Claudia P. ;
Abreu, Jose G. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
[40]   Regulation of carcinogenesis and modulation through Wnt/β-catenin signaling by curcumin in an ovarian cancer cell line [J].
Yen, Hsing-Yu ;
Tsao, Chih-Wei ;
Lin, Ya-Wen ;
Kuo, Chih-Chi ;
Tsao, Chang-Huei ;
Liu, Chin-Yu .
SCIENTIFIC REPORTS, 2019, 9 (1)